BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Endocrine gland cancer AND STAT5B, STAT5, 6777, ENSG00000173757, P51692 AND Prognosis
13 results:

  • 1. Nuclear PLD1 combined with NPM1 induces gemcitabine resistance through tumorigenic IL7R in pancreatic adenocarcinoma.
    Fu D; Yan J; Zhang Z; Liu Y; Ma X; Ding J; Yang S; Zhao R; Chang A; Gao C; Liu J; Zhao T; Wang X; Huang C; Gao S; Ma Y; Tang B; Feng Y; Wang H; Hao J
    Cancer Biol Med; 2023 Jun; 20(8):599-626. PubMed ID: 37381714
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. A novel immune checkpoint score system for prognostic evaluation in pancreatic adenocarcinoma.
    Chen Y; Lin X; Zou X; Qian Y; Liu Y; Wang R; Wang X; Yu X; Liu C; Cheng H
    BMC Gastroenterol; 2023 Apr; 23(1):113. PubMed ID: 37024802
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. PDP1 Promotes Cell Malignant Behavior and Is Associated with Worse Clinical Features in Ovarian cancer Patients: Evidence from Bioinformatics and In Vitro Level.
    Song Y; Zhang J; Zhang L; Zhang S; Shen C
    Comput Math Methods Med; 2022; 2022():7397250. PubMed ID: 36276992
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Exploration of the underlying biological differences and targets in ovarian cancer patients with diverse immunotherapy response.
    Chen J; Chen S; Dai X; Ma L; Chen Y; Bian W; Sun Y
    Front Immunol; 2022; 13():1007326. PubMed ID: 36189254
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Pancreatic cancer is associated with aberrant monocyte function and successive differentiation into macrophages with inferior anti-tumour characteristics.
    Juusola M; Kuuliala K; Kuuliala A; Mustonen H; Vähä-Koskela M; Puolakkainen P; Seppänen H
    Pancreatology; 2021 Mar; 21(2):397-405. PubMed ID: 33461933
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Using The cancer Genome Atlas data to refine the 8th edition of the American Joint Committee on cancer staging for papillary thyroid carcinoma.
    Poma AM; Macerola E; Torregrossa L; Elisei R; Santini F; Basolo F
    Endocrine; 2021 Apr; 72(1):140-146. PubMed ID: 32915437
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Fibroblasts as a Biological Marker for Curative Resection in Pancreatic Ductal Adenocarcinoma.
    Katsuta E; Rashid OM; Takabe K
    Int J Mol Sci; 2020 May; 21(11):. PubMed ID: 32485981
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Poziotinib suppresses ovarian cancer stem cell growth via inhibition of HER4-mediated stat5 pathway.
    Lee H; Kim JW; Choi DK; Yu JH; Kim JH; Lee DS; Min SH
    Biochem Biophys Res Commun; 2020 May; 526(1):158-164. PubMed ID: 32201081
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Autocrine activation of JAK2 by IL-11 promotes platinum drug resistance.
    Zhou W; Sun W; Yung MMH; Dai S; Cai Y; Chen CW; Meng Y; Lee JB; Braisted JC; Xu Y; Southall NT; Shinn P; Huang X; Song Z; Chen X; Kai Y; Cai X; Li Z; Hao Q; Cheung ANY; Ngan HYS; Liu SS; Barak S; Hao J; Dai Z; Tzatsos A; Peng W; Pei H; Han Z; Chan DW; Zheng W; Zhu W
    Oncogene; 2018 Jul; 37(29):3981-3997. PubMed ID: 29662190
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. The prognostic values of signal transducers activators of transcription family in ovarian cancer.
    Li S; Sheng B; Zhao M; Shen Q; Zhu H; Zhu X
    Biosci Rep; 2017 Aug; 37(4):. PubMed ID: 28536310
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. stat5b as molecular target in pancreatic cancer--inhibition of tumor growth, angiogenesis, and metastases.
    Moser C; Ruemmele P; Gehmert S; Schenk H; Kreutz MP; Mycielska ME; Hackl C; Kroemer A; Schnitzbauer AA; Stoeltzing O; Schlitt HJ; Geissler EK; Lang SA
    Neoplasia; 2012 Oct; 14(10):915-25. PubMed ID: 23097626
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Favorable prognostic value of SOCS2 and IGF-I in breast cancer.
    Haffner MC; Petridou B; Peyrat JP; Révillion F; Müller-Holzner E; Daxenbichler G; Marth C; Doppler W
    BMC Cancer; 2007 Jul; 7():136. PubMed ID: 17651480
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. stat5 expression predicts response to endocrine therapy and improves survival in estrogen receptor-positive breast cancer.
    Yamashita H; Nishio M; Ando Y; Zhang Z; Hamaguchi M; Mita K; Kobayashi S; Fujii Y; Iwase H
    Endocr Relat Cancer; 2006 Sep; 13(3):885-93. PubMed ID: 16954437
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.